ANDA 75899, held by Synthon Pharms. Fluvoxamine Maleate.
As of Nov 16, 2026, ANDA 75899 (Fluvoxamine Maleate), held by Synthon Pharms, was first approved by FDA on Jan 17, 2001, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 17, 2001 | Original application | Approved |
| Fluvoxamine Maleate25MG · tablet;oral | Fluvoxamine Maleate | Discontinued |
| Fluvoxamine Maleate50MG · tablet;oral | Fluvoxamine Maleate | Discontinued |
| Fluvoxamine Maleate100MG · tablet;oral | Fluvoxamine Maleate | Discontinued |
| Oct 16, 2007 | Supplement 10Labeling | Approved | None posted |
| Jun 29, 2007 | Supplement 9Labeling | Approved | None posted |
| Oct 18, 2006 | Supplement 8Labeling | Approved | None posted |
| Jul 8, 2005 | Supplement 7Labeling | Approved | None posted |
| Apr 14, 2005 | Supplement 6Labeling | Approved | None posted |
| Apr 14, 2005 | Supplement 5Labeling | Approved | None posted |
| Nov 20, 2004 | Supplement 4Labeling | Approved | None posted |
| Sep 25, 2003 | Supplement 3Labeling | Approved | None posted |
| Jul 24, 2002 | Supplement 2Labeling | Approved | None posted |
| Jan 17, 2001 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters